Home / 510(k) Clearances / K232017

510(k) K232017

ARK Methotrexate II Assay by ARK Diagnostics, Inc. — Product Code LAO

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 20, 2023
Date Received
July 7, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Immunoassay, Methotrexate
Device Class
Class U
Regulation Number
Review Panel
TX
Submission Type

Other clearances by ARK Diagnostics, Inc.

  • K232522 — ARK Levetiracetam II Assay (February 27, 2024)
  • K231752 — ARK Hydrocodone Assay (November 9, 2023)
  • K201089 — ARK Lacosamide Assay (August 5, 2021)
  • K200197 — ARK Fentanyl II Assay (February 26, 2020)
  • K182280 — ARK Tramadol Assay (December 10, 2018)
  • K182779 — ARK EDDP Assay (November 21, 2018)
  • K180427 — ARK Fentanyl Assay (June 6, 2018)
  • K163359 — ARK Methotrexate Assay (August 18, 2017)
  • DEN160033 — ARK Voriconazole II Assay Test System (May 5, 2017)
  • K153596 — ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK (August 9, 2016)

Other clearances for product code LAO

  • K233454 — ONLINE TDM Methotrexate (February 20, 2024)
  • K163359 — ARK Methotrexate Assay (August 18, 2017)
  • K111904 — ARK METHOTREXATE ASSAY, ARK METHOTREXATE CALIBRATOR, ARK METHOTREXATE CONTROL, A (October 18, 2011)
  • K932615 — TDX(R)/TDX(R)FLX(R)MEHTOTREXATE II (July 14, 1993)
  • K884744 — ACA DU PONT METHOTREXATE (MTHO) METHOD (January 30, 1989)
  • K833634 — EMIT & METHOFREXATE ASSAY (December 22, 1983)
  • K830398 — TDX METHOTREXATE (March 10, 1983)
  • K811459 — EMIT-AND METHOTREXATE ASSAY (June 9, 1981)
  • K781381 — EMIT METHATREXATE ASSAY (October 10, 1978)